Cargando…
Crosstalk between ERK, AKT, and cell survival
It is historically well known that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.(1)(-)(3) Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling b...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974823/ https://www.ncbi.nlm.nih.gov/pubmed/24424114 http://dx.doi.org/10.4161/cbt.27541 |
_version_ | 1782310055317602304 |
---|---|
author | Dent, Paul |
author_facet | Dent, Paul |
author_sort | Dent, Paul |
collection | PubMed |
description | It is historically well known that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.(1)(-)(3) Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling by another.(4) Signaling by the ERK1/2 pathway can also stimulate release of growth factors which can feed back onto tumor cells to re-energize signaling pathways.(5) The studies described by Toulany et al. add to this knowledge base by examining the relationship between PI3K-AKT and MEK1/2-ERK1/2 pathway signaling, EGF receptor signaling, K-RAS function, and tumor cell survival.(6) |
format | Online Article Text |
id | pubmed-3974823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-39748232014-04-07 Crosstalk between ERK, AKT, and cell survival Dent, Paul Cancer Biol Ther Commentary It is historically well known that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.(1)(-)(3) Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling by another.(4) Signaling by the ERK1/2 pathway can also stimulate release of growth factors which can feed back onto tumor cells to re-energize signaling pathways.(5) The studies described by Toulany et al. add to this knowledge base by examining the relationship between PI3K-AKT and MEK1/2-ERK1/2 pathway signaling, EGF receptor signaling, K-RAS function, and tumor cell survival.(6) Landes Bioscience 2014-03-01 2014-01-14 /pmc/articles/PMC3974823/ /pubmed/24424114 http://dx.doi.org/10.4161/cbt.27541 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Commentary Dent, Paul Crosstalk between ERK, AKT, and cell survival |
title | Crosstalk between ERK, AKT, and cell survival |
title_full | Crosstalk between ERK, AKT, and cell survival |
title_fullStr | Crosstalk between ERK, AKT, and cell survival |
title_full_unstemmed | Crosstalk between ERK, AKT, and cell survival |
title_short | Crosstalk between ERK, AKT, and cell survival |
title_sort | crosstalk between erk, akt, and cell survival |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974823/ https://www.ncbi.nlm.nih.gov/pubmed/24424114 http://dx.doi.org/10.4161/cbt.27541 |
work_keys_str_mv | AT dentpaul crosstalkbetweenerkaktandcellsurvival |